In addition, many of the interleukins (ILs) including IL-6, IL-17, IL-23, and IL-26, among others, have been implicated in IBD pathogenesis and its complications [8,9,10], while IL-10 signaling through its receptors plays a protective role against IBD development [11,12,13]. The gene discussed is IL26; the disease is irritable bowel syndrome.